Related Experiment Video
Updated: Jan 29, 2026
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Melatonin supplementation reduces delirium incidence in critically ill patients: a systematic review and
Xiaoyu Wu1, Panxin Hu1, Haopeng Wu1
1Department of Emergency Medicine, The First People's Hospital of Taizhou, Taizhou, China.
Background:
Delirium represents a common and severe neuropsychiatric complication among critically ill individuals, often leading to extended hospital stays, elevated mortality risk, and persistent cognitive decline. Disruption of circadian sleep-wake rhythms is a major pathogenic factor, implying that melatonin may hold therapeutic potential in this context. Nonetheless, evidence regarding the effectiveness of melatonin in preventing delirium among patients in intensive care unit (ICU) remains inconsistent.
Objective:
This meta-analysis aimed to systematically evaluate the effects of melatonin and melatonin receptor agonists on the incidence and duration of delirium, length of ICU stay, and mortality among adult critically ill patients.
Methods:
We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs). A comprehensive search was performed in PubMed, Embase, Scopus, and Cochrane CENTRAL from inception until 10 October 2025. Only RCTs comparing melatonin or ramelteon with placebo or standard care in adult ICU patients were included. The primary outcome was the incidence of delirium. Secondary outcomes included duration of delirium, length of ICU stay, and overall mortality.
Results:
A total of 22 RCTs involving 3706 patients were included. Pooled analysis demonstrated that melatonin administration was associated with a significant reduction in the incidence of delirium compared to the control group (Risk Ratio [RR] 0.75, 95% Confidence Interval [CI] 0.63 to 0.90, P = 0.001, I2 = 50%). However, melatonin did not significantly affect the duration of delirium (Mean Difference [MD] 0.18 days, 95% CI -0.16 to 0.52, P = 0.56, I2 = 45%), length of ICU stay (MD -0.45 days, 95% CI -1.10 to 0.20, P = 0.09, I2 = 68%), or overall mortality (RR 0.92, 95% CI 0.79 to 1.06, P = 0.25, I2 = 0%).
Conclusion:
Among critically ill adults, melatonin supplementation is effective in reducing the incidence of delirium. However, it does not appear to shorten the duration of delirium, reduce ICU stay, or improve survival. These findings support the use of melatonin for delirium prevention but suggest its benefits may be limited to reducing occurrence rather than altering the course of established delirium or other clinical outcomes.
Systematic Review Registration:
https://osf.io/95je7.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
05:01A Detailed Protocol for Physiological Parameters Acquisition and Analysis in Neurosurgical Critical Patients
Published on: October 17, 2017
Related Concept Videos
01:08Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
01:10Review and Preview
Percentiles are a type of fractile that partition data into...
01:13Review and Preview
01:16Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...
01:31Critical Values
01:20Random and Systematic Errors